Copyright
©2007 Baishideng Publishing Group Co.
World J Gastroenterol. May 21, 2007; 13(19): 2697-2702
Published online May 21, 2007. doi: 10.3748/wjg.v13.i19.2697
Published online May 21, 2007. doi: 10.3748/wjg.v13.i19.2697
Characteristics | Risk Ratio | 95% CI of risk ratio | P |
Age | 0.30 | ||
Less than 40 yr | 1 | ||
More than 41 yr | 2.1 | 0.4-9.6 | |
Sex | 0.70 | ||
Male | 1 | ||
Female | 0.7 | 0.3-1.7 | |
Location | 0.02 | ||
Distal | 1 | ||
Non-distal | 3.2 | 1.3-7.8 | |
Histologic type | 0.70 | ||
Intestinal | 1 | ||
Non-intestinal | 0.5 | 0.3-1.7 | |
T stage | 0.02 | ||
T1 + T2 | 1 | ||
T3 + T4 | 4.1 | 1.2-13.6 | |
N stage | 0.05 | ||
Negative | 1 | ||
Positive | 7.7 | 1-61.5 | |
NAT2 | 0.18 | ||
Slow | 1 | ||
Rapid | 1.9 | 0.7-5.0 | |
H pylori Status | 0.90 | ||
Negative | 1 | ||
Positive | 1.1 | 0.4-3.0 |
-
Citation: Al-Moundhri MS, Al-Kindi M, Al-Nabhani M, Al-Bahrani B, Burney IA, Al-Madhani A, Ganguly SS, Tanira M.
NAT2 polymorphism in Omani gastric cancer patients-risk predisposition and clinicopathological associations. World J Gastroenterol 2007; 13(19): 2697-2702 - URL: https://www.wjgnet.com/1007-9327/full/v13/i19/2697.htm
- DOI: https://dx.doi.org/10.3748/wjg.v13.i19.2697